Physician

Amy Valette Curtis, MD

According to 2025 Medicare claims, Amy Curtis, MD (NPI: 1841499084) practices dermatology in the Ogden, UT market, with the plurality of this provider's patient population coming from Davis, UT. This provider's primary affiliated billing organization is INTEGRATED DERMATOLOGY OF BOUNTIFUL LLC (NPI: 1629396841; TIN: 272553261) and primary practice location at 84014-9998.

Curtis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 598 traditional Medicare patients, billed 11,917 HCPCS/CPT codes, and received $287,774 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 805 prescription claims across 402 beneficiaries totaling $27,804 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 3 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $41,359 and ending at $27,804. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$167K$335K2015 Medicare payment: $255,221 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $236,720 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $283,142 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $294,935 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $295,465 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $292,503 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $334,722 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $280,358 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $319,654 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $287,774 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157885,490$255,221
20167325,101$236,720
20177396,057$283,142
201876011,387$294,935
20197748,163$295,465
202072211,857$292,503
20216879,501$334,722
20226458,607$280,358
20236407,971$319,654
202459811,917$287,774

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$148K$296K2015 Drug cost: $41,359 (USD; Tot_Drug_Cst)2016 Drug cost: $41,835 (USD; Tot_Drug_Cst)2017 Drug cost: $22,205 (USD; Tot_Drug_Cst)2018 Drug cost: $26,783 (USD; Tot_Drug_Cst)2019 Drug cost: $59,345 (USD; Tot_Drug_Cst)2020 Drug cost: $111,218 (USD; Tot_Drug_Cst)2021 Drug cost: $296,311 (USD; Tot_Drug_Cst)2022 Drug cost: $126,801 (USD; Tot_Drug_Cst)2023 Drug cost: $84,812 (USD; Tot_Drug_Cst)2024 Drug cost: $27,804 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015317726$41,359
2016279618$41,835
2017266583$22,205
2018282566$26,783
2019323696$59,345
2020323678$111,218
2021311704$296,311
2022322637$126,801
2023326680$84,812
2024402805$27,804

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths355628$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more274392$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more402641$64
17000Destruction of precancer skin growth, 1 growth288356$32
17003Destruction of precancer skin growth, 2-14 growths2631,779$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate1243,221$4,598
FluorouracilFluorouracil542,014$3,496
ValacyclovirValacyclovir Hcl72948$2,391
KetoconazoleKetoconazole701,930$957
Triamcinolone AcetonideTriamcinolone Acetonide1763,244$765

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$88Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amy Valette Curtis, MD?

Tedicare shows public-source Medicare data for Amy Valette Curtis, MD (NPI 1841499084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Valette Curtis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy Valette Curtis, MD?

Amy Valette Curtis, MD is linked to INTEGRATED DERMATOLOGY OF BOUNTIFUL LLC (billing NPI 1629396841) in the available physician profile data.

Does Amy Valette Curtis, MD have Open Payments data?

Amy Valette Curtis, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.